Scientists Are Using Microparticles, to Develop a, Self-Boosting Vaccine.<br />'Newsweek' reports that scientists are developing <br />a one-jab, self-boosting vaccine that can <br />deliver multiple doses at different times.<br />According to new research, one shot <br />could provide multiple rounds of <br />inoculation thanks to microparticles.<br />Scientists claim the microparticles <br />could be used to combat a number of <br />illnesses, including measles and COVID.<br />The team at MIT's Koch Institute for Integrative Cancer Research <br />in Cambridge, Massachusetts, says the technology could be <br />particularly useful for administering childhood vaccinations.<br />This is a platform that can be broadly <br />applicable to all types of vaccines, <br />including recombinant protein-based <br />vaccines, DNA-based vaccines, <br />even RNA-based vaccines, Dr. Ana Jaklenec, <br />senior author of the study, <br />via 'Newsweek'.<br />Understanding the process <br />of how the vaccines are released, <br />which is what we described in this paper, <br />has allowed us to work on formulations <br />that address some of the instability <br />that could be induced over time, Dr. Ana Jaklenec, <br />senior author of the study, <br />via 'Newsweek'.<br />'Newsweek' reports that the particles are made from PLGA, a biocompatible polymer already approved for use in medical and prosthetic devices. .<br />We believe these core shell particles <br />have the potential to create a safe, <br />single-injection, self-boosting vaccine <br />in which a cocktail of particles with <br />different release times can be created <br />by changing the composition, Professor Robert Langer, <br />co-senior author of the study, <br />via 'Newsweek'.<br />Such a single injection approach has the <br />potential to not only improve patient <br />compliance but also increase cellular and <br />humoral immune responses to the vaccine, Professor Robert Langer, <br />co-senior author of the study, <br />via 'Newsweek'.<br />Such a single injection approach has the <br />potential to not only improve patient <br />compliance but also increase cellular and <br />humoral immune responses to the vaccine, Professor Robert Langer, <br />co-senior author of the study, <br />via 'Newsweek'
